NCT07027046Recruiting
Application of da Vinci SP for Endometrial Cancer Surgical Staging
Application of da Vinci SP for Endometrial Cancer Surgical Staging: a Prospective Multicenter Study
Source: ClinicalTrials.gov · Last updated 19 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Prospective Multicenter Observational Study The study involves the consecutive inclusion of every patient with endometrial cancer undergoing staging surgical treatment using a robotic approach with the da Vinci SP platform.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 564 (estimated)
- First submitted
- 30 May 2025
- Start date
- 3 Apr 2025
- Primary completion date
- Jun 2026
- Lead sponsor
- National Cancer Institute, Naples
- Diseases
- Endometrial cancer
- NCT number
- NCT07027046
What you commit to
- Study type: Observational
- Planned participants: 564
- From 3 Apr 2025 to the primary completion date, Jun 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients scheduled for an additional extra-genital surgical procedure during the staging surgery for endometrial carcinoma
- Any reason that may interfere with regular follow-up, even if limited to the first 30 days post-surgery
Other illness
- Dementia or significantly altered mental status that may impair understanding and the ability to provide informed consent
Other
- Patients with anesthesiological contraindications to a minimally invasive approach
- Synchronous tumor
- Recurrence of endometrial carcinoma
Who the study is looking for
- Age ≥ 18 years
- Histologically confirmed endometrial carcinoma (including uterine carcinosarcoma)
- Performance status (ECOG) 0 - 1
- Patients undergoing staging surgery for endometrial cancer, including but not limited to robotic hysterectomy with bilateral salpingo-oophorectomy (ovarian preservation in selected patients is not an exclusion criterion) and possible sentinel lymph node biopsy/pelvic ± para-aortic lymphadenectomy
- Signed informed consent to participate in the study
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IEO Istituto Europeo di Oncologia Coordinator of this site? Confirm its status | Milan | Italy | Recruiting |
| Istituto Nazionale Tumori Fondazione Pascale Coordinator of this site? Confirm its status | Naples | Italy | Recruiting |
| Istituti Fisioterapici Ospitalieri (IFO) Coordinator of this site? Confirm its status | Roma | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.